lung cancer

Revolutionary molecule against lung cancer

Sadly aware of the fact that against lung cancer, which currently affects about 37,000 people every year in Italy alone, there are still few effective treatments, the pharmaceutical company Pharmion has announced the launch of an international phase III study on the treatment of small cell lung cancer with amrubicin (a new fully synthetic anthracycline).… Continua a leggere Revolutionary molecule against lung cancer